재정 지원 요구사항을 통해 공개된 자료 - Juergen Braun자세히 알아보기
제공된 곳이 없음: 1
Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes
J Sieper, H Appel, J Braun, M Rudwaleit
Arthritis & Rheumatism: Official Journal of the American College of …, 2008
재정 지원 요구사항 정책: German Research Foundation
제공된 곳이 있음: 14
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M Rudwaleit, D Van Der Heijde, R Landewé, J Listing, N Akkoc, J Brandt, ...
Annals of the rheumatic diseases 68 (6), 777-783, 2009
재정 지원 요구사항 정책: Versus Arthritis, UK
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
J Braun, R van den Berg, X Baraliakos, H Boehm, R Burgos-Vargas, ...
Annals of the rheumatic diseases 70 (6), 896-904, 2011
재정 지원 요구사항 정책: Versus Arthritis, UK
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
D Baeten, X Baraliakos, J Braun, J Sieper, P Emery, D Van der Heijde, ...
The Lancet 382 (9906), 1705-1713, 2013
재정 지원 요구사항 정책: Versus Arthritis, UK
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
JS Smolen, J Braun, M Dougados, P Emery, O FitzGerald, P Helliwell, ...
Annals of the rheumatic diseases 73 (1), 6-16, 2014
재정 지원 요구사항 정책: US National Institutes of Health, Versus Arthritis, UK
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ...
Annals of the rheumatic diseases 71 (1), 4-12, 2012
재정 지원 요구사항 정책: Versus Arthritis, UK
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo …
R Landewé, J Braun, A Deodhar, M Dougados, WP Maksymowych, ...
Annals of the rheumatic diseases 73 (1), 39-47, 2014
재정 지원 요구사항 정책: US National Institutes of Health
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised …
IB McInnes, J Sieper, J Braun, P Emery, D van der Heijde, JD Isaacs, ...
Annals of the rheumatic diseases 73 (2), 349-356, 2014
재정 지원 요구사항 정책: Versus Arthritis, UK
Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double‐blind …
M Dougados, D van der Heijde, J Sieper, J Braun, WP Maksymowych, ...
Arthritis & rheumatology 66 (8), 2091-2102, 2014
재정 지원 요구사항 정책: National Institute of Health and Medical Research, France
Predicting the outcome of ankylosing spondylitis therapy
N Vastesaeger, D Van Der Heijde, RD Inman, Y Wang, A Deodhar, B Hsu, ...
Annals of the rheumatic diseases 70 (6), 973-981, 2011
재정 지원 요구사항 정책: Research Foundation (Flanders)
Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS
U Kiltz, D Van Der Heijde, A Boonen, A Cieza, G Stucki, MA Khan, ...
Annals of the rheumatic diseases 74 (5), 830-835, 2015
재정 지원 요구사항 정책: US National Institutes of Health
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and …
X Baraliakos, F Heldmann, J Callhoff, J Listing, T Appelboom, J Brandt, ...
Annals of the rheumatic diseases 73 (10), 1819-1825, 2014
재정 지원 요구사항 정책: Versus Arthritis, UK, National Institute for Health Research, UK
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008
DE Furst, EC Keystone, B Kirkham, R Fleischmann, P Mease, ...
Annals of the rheumatic diseases 67 (Suppl 3), iii2-iii25, 2008
재정 지원 요구사항 정책: Versus Arthritis, UK
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target …
MM Schoels, J Braun, M Dougados, P Emery, O Fitzgerald, A Kavanaugh, ...
Annals of the rheumatic diseases 73 (1), 238-242, 2014
재정 지원 요구사항 정책: Versus Arthritis, UK
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long-term outcomes in patients with ankylosing spondylitis treated with infliximab
F Heldmann, J Brandt, IE Van der Horst-Bruinsma, R Landewe, J Sieper, ...
Clinical and Experimental Rheumatology-Incl Supplements 29 (4), 672, 2011
재정 지원 요구사항 정책: Versus Arthritis, UK
발행인 및 자금 지원 정보는 컴퓨터 프로그램에서 자동으로 결정됩니다.